Nykode Therapeutics Swings To Q2 Profit

(RTTNews) - Nykode Therapeutics AS (VACBF, NYKD.OL), an Oslo-based clinical-stage biopharmaceutical platform, on Wednesday it reported profit in the second quarter compared with the previous year.

For the second quarter, profit came in at $859 million compared with loss of $7.39 billion in the prior year.

Operating loss narrowed to $6.68 billion from $11.79 billion in the prior year.

However, revenue for the quarter declined to $198 million from $584 million in the previous year.

On Tuesday, Nykode Therapeutics closed trading, 3.89% lesser at NOK 1.7300 on the Oslo Stock Exchange.